HedgePath Pharmaceuticals, Inc. Facility Agreements
3 Contracts & Agreements
- Letter Agreement to Amend Term Debt Facility, dated March 9, 2022, between the Company and Mayne Pharma (Filed With SEC on March 30, 2022)
- Letter Agreement to Amend Term Debt Facility, dated January 13, 2022, between the Company and Mayne Pharma (Filed With SEC on January 18, 2022)
- Letter Agreement for Term Debt Facility, dated December 12, 2020, between the Company and Mayne Pharma (Filed With SEC on December 17, 2020)